» Articles » PMID: 28958013

Fracture Risk Assessment in Long-term Care (FRAiL): Development and Validation of a Prediction Model

Overview
Specialty Geriatrics
Date 2017 Sep 29
PMID 28958013
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Strategies used to predict fracture in community-dwellers may not be useful in the nursing home (NH). Our objective was to develop and validate a model (Fracture Risk Assessment in Long-term Care [FRAiL]) to predict the 2-year risk of hip fracture in NH residents using readily available clinical characteristics.

Methods: The derivation cohort consisted of 419,668 residents between May 1, 2007 and April 30, 2008 in fee-for service Medicare. Hip fractures were identified using Part A diagnostic codes. Resident characteristics were obtained using the Minimum Data Set and Part D claims. Multivariable competing risk regression was used to model 2-year risk of hip fracture. We validated the model in a remaining 1/3 sample (n = 209,834) and in a separate cohort in 2011 (n = 858,636).

Results: Mean age was 84 years (range 65-113 years) and 74.5% were female. During 1.8 years mean follow-up, 14,553 residents (3.5%) experienced a hip fracture. Fifteen characteristics in the final model were associated with an increased risk of hip fracture including dementia severity, ability to transfer and walk independently, prior falls, wandering, and diabetes. In the derivation sample, the concordance index was 0.69 in men and 0.71 in women. Calibration was excellent. Results were similar in the internal and external validation samples.

Conclusions: The FRAiL model was developed specifically to identify NH residents at greatest risk for hip fracture, and it identifies a different pattern of risk factors compared with community models. This practical model could be used to screen NH residents for fracture risk and to target intervention strategies.

Citing Articles

Hip fracture rate and osteoporosis treatment in Ontario: A population-based retrospective cohort study.

AbuAlrob H, Ioannidis G, Jaglal S, Costa A, Grifith L, Thabane L Arch Osteoporos. 2024; 19(1):53.

PMID: 38918265 PMC: 11199290. DOI: 10.1007/s11657-024-01402-6.


Predictive value of machine learning on fracture risk in osteoporosis: a systematic review and meta-analysis.

Wu Y, Chao J, Bao M, Zhang N BMJ Open. 2023; 13(12):e071430.

PMID: 38070927 PMC: 10728980. DOI: 10.1136/bmjopen-2022-071430.


Nursing Home PRevention of Injury in DEmentia (NH PRIDE): A pilot study of a remote injury prevention service for NH residents.

Berry S, Hecker E, McConnell E, Xue T, Tsai T, Zullo A J Am Geriatr Soc. 2023; 71(10):3267-3277.

PMID: 37596877 PMC: 10592133. DOI: 10.1111/jgs.18564.


Prescriber Perspectives and Experiences with Deprescribing Versus Continuing Bisphosphonates in Older Nursing Home Residents with Dementia.

Niznik J, Colon-Emeric C, Thorpe C, Kelley C, Gilliam M, Lund J J Gen Intern Med. 2023; 38(15):3372-3380.

PMID: 37369891 PMC: 10682438. DOI: 10.1007/s11606-023-08275-4.


Perceptions and practices of aged care pharmacists regarding osteoporosis management: a qualitative study.

Laird C, Williams K, Benson H Int J Clin Pharm. 2023; 45(4):913-921.

PMID: 37162657 PMC: 10366014. DOI: 10.1007/s11096-023-01586-w.


References
1.
. American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2015; 63(11):2227-46. DOI: 10.1111/jgs.13702. View

2.
Greenspan S, Schneider D, McClung M, Miller P, Schnitzer T, Bonin R . Alendronate improves bone mineral density in elderly women with osteoporosis residing in long-term care facilities. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2002; 136(10):742-6. DOI: 10.7326/0003-4819-136-10-200205210-00009. View

3.
Greenspan S, Nace D, Perera S, Ferchak M, Fiorito G, Medich D . Lessons learned from an osteoporosis clinical trial in frail long-term care residents. Clin Trials. 2011; 9(2):247-56. PMC: 3889110. DOI: 10.1177/1740774511430516. View

4.
Greenspan S, Perera S, Ferchak M, Nace D, Resnick N . Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. JAMA Intern Med. 2015; 175(6):913-21. PMC: 4843134. DOI: 10.1001/jamainternmed.2015.0747. View

5.
Beaupre L, Jones C, Johnston D, Wilson D, Majumdar S . Recovery of function following a hip fracture in geriatric ambulatory persons living in nursing homes: prospective cohort study. J Am Geriatr Soc. 2012; 60(7):1268-73. DOI: 10.1111/j.1532-5415.2012.04033.x. View